metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome ...
Journal Information

Statistics

Follow this link to access the full text of the article

RAPID COMMUNICATION
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
José Gomes BatistaI,,II,
Corresponding author
jsoares415@hotmail.com

Tel.: 55 11 5081-3865
, José Maria Soares JrI,,III, Carla Cristina MaganhinI, Ricardo Santos SimõesIII, Geraldez TomazII, Edmund Chada BaracatI,III
I Federal University of São Paulo (UNIFESP), Gynecology Department, São Paulo/SP, Brazil
II Federal University of Paraíba (UFPB), Obstetrics and Gynecology Department, João Pessoa/PB, Brazil
III Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Gynecology Department, São Paulo/SP, Brazil
Read
595
Times
was read the article
286
Total PDF
309
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 11 1 12
2024 November 36 17 53
2024 October 17 20 37
2024 September 21 22 43
2024 August 36 27 63
2024 July 14 19 33
2024 June 20 8 28
2024 May 14 15 29
2024 April 14 20 34
2024 March 15 14 29
2024 February 9 10 19
2024 January 12 8 20
2023 December 8 15 23
2023 November 10 16 26
2023 October 11 21 32
2023 September 12 21 33
2023 August 9 8 17
2023 July 6 10 16
2023 June 7 1 8
2023 May 2 0 2
2023 April 3 1 4
2023 March 7 0 7
2023 February 9 11 20
2023 January 3 0 3
2022 December 3 1 4
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos